Excelerate Health Ventures

Type

Venture Capital

Status

Active

Location

Durham, United States

Total investments

28

Average round size

4M

Portfolio companies

18

Rounds per year

2.80

Lead investments

6

Follow on index

0.36

Exits

3

Stages of investment
SeedEarly Stage Venture
Areas of investment
PublishingSoftwareAnalyticsInformation TechnologyHealth CareHospitalSaaSEducationMedicalRisk Management

Summary

In 2014 was created Excelerate Health Ventures, which is appeared as VC. The main office of represented VC is situated in the Raleigh. The venture was found in North America in United States.

Deals in the range of 5 - 10 millions dollars are the general things for fund. Comparing to the other companies, this Excelerate Health Ventures performs on 18 percentage points less the average number of lead investments. Considering the real fund results, this VC is 2 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The increased amount of exits for fund were in 2018. When the investment is from Excelerate Health Ventures the average startup value is 1-5 millions dollars. The fund is constantly included in 2-6 investment rounds annually.

Among the most successful fund investment fields, there are Analytics, Business Intelligence. The fund has exact preference in some founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Medikidz, Inc., Bivarus, NurseGrid For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.

The current fund was established by Bobby Bahram, Gary Abrahams.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Excelerate Health Ventures, startups are often financed by Portland Seed Fund, Hatteras Venture Partners, Shumway Capital. The meaningful sponsors for the fund in investment in the same round are Hatteras Venture Partners, LRVHealth, Toba Capital. In the next rounds fund is usually obtained by Hatteras Venture Partners, NueCura Partners, LLC, LRVHealth.

Show more

Investor highlights

Industry focus
HealthcareFuture of Work
Stage focus
GeneralistSeedSeries ASeries B

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 35000000
Fund raised date
2021-01-15

Analytics

Total investments
28
Lead investments
6
Exits
3
Rounds per year
2.80
Follow on index
0.36
Investments by industry
  • Health Care (24)
  • Medical (9)
  • SaaS (7)
  • Information Technology (6)
  • Hospital (5)
  • Show 29 more
Investments by region
  • United States (28)
Peak activity year
2018
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
8
Avg. valuation at time of investment
79M
Group Appearance index
0.86
Avg. company exit year
7
Avg. multiplicator
66.26
Strategy success index
0.10

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Bivarus 11 Feb 2015 Analytics, Health Care Early Stage Venture 1M United States, North Carolina, Durham
Notes.io 11 Jan 2019 Publishing, Software, Web Apps, iOS, Scheduling Seed 8K Istanbul, Istanbul, Turkey
S2N Health 23 May 2024 Seed United States, Massachusetts, Boston

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.